524 related articles for article (PubMed ID: 25398491)
1. Role of IL-17 and IL-22 in autoimmunity and cancer.
Blake SJ; Teng MW
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
[TBL] [Abstract][Full Text] [Related]
2. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
[TBL] [Abstract][Full Text] [Related]
3. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.
Roeleveld DM; Koenders MI
Cytokine; 2015 Jul; 74(1):101-7. PubMed ID: 25466295
[TBL] [Abstract][Full Text] [Related]
4. Targeting IL-17 in autoimmunity and inflammation.
Kim BS; Park YJ; Chung Y
Arch Pharm Res; 2016 Nov; 39(11):1537-1547. PubMed ID: 27576555
[TBL] [Abstract][Full Text] [Related]
5. Functional specialization of interleukin-17 family members.
Iwakura Y; Ishigame H; Saijo S; Nakae S
Immunity; 2011 Feb; 34(2):149-62. PubMed ID: 21349428
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.
Kramer JM; Gaffen SL
J Periodontol; 2007 Jun; 78(6):1083-93. PubMed ID: 17539723
[TBL] [Abstract][Full Text] [Related]
7. Exploring the role of interleukin-22 in neurological and autoimmune disorders.
Xin N; Namaka MP; Dou C; Zhang Y
Int Immunopharmacol; 2015 Oct; 28(2):1076-83. PubMed ID: 26311525
[TBL] [Abstract][Full Text] [Related]
8. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Zhu S; Qian Y
Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of targeting IL-17.
Jones SA; Sutton CE; Cua D; Mills KH
Nat Immunol; 2012 Nov; 13(11):1022-5. PubMed ID: 23080193
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
Dallenbach K; Maurer P; Röhn T; Zabel F; Kopf M; Bachmann MF
Eur J Immunol; 2015 Apr; 45(4):1238-47. PubMed ID: 25545966
[TBL] [Abstract][Full Text] [Related]
11. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
[TBL] [Abstract][Full Text] [Related]
12. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
Yamagata T; Skepner J; Yang J
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
[TBL] [Abstract][Full Text] [Related]
13. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
14. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
Leng RX; Pan HF; Tao JH; Ye DQ
Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-22: a likely target for treatment of autoimmune diseases.
Yang X; Zheng SG
Autoimmun Rev; 2014 Jun; 13(6):615-20. PubMed ID: 24418299
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 and innate immunity in infections and chronic inflammation.
Isailovic N; Daigo K; Mantovani A; Selmi C
J Autoimmun; 2015 Jun; 60():1-11. PubMed ID: 25998834
[TBL] [Abstract][Full Text] [Related]
17. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis.
Chiricozzi A
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():9-20. PubMed ID: 25398488
[TBL] [Abstract][Full Text] [Related]
19. Targeting IL-23 in autoimmunity.
Hölscher C
Curr Opin Investig Drugs; 2005 May; 6(5):489-95. PubMed ID: 15912962
[TBL] [Abstract][Full Text] [Related]
20. Targeting Th17 cells in autoimmune diseases.
Yang J; Sundrud MS; Skepner J; Yamagata T
Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]